“…Studies of the prevalence and correlates of GBV-C infection among different populations have identified many risk factors for GBV-C infection, including, IDU [Katayama et al, 1997;Saganuma et al, 1998;Tan et al, 1999;Lefrere et al, 1999a;Christensen et al, 2003;Vanhems et al, 2003], receipt of blood transfusion [Stark et al, 1999;Tan et al, 1999;Henrichsen et al, 2002], increased number of sexual partners [Wu et al, 1997;Bjorkman et al, 2001;Ribeiro-dos-Santos et al, 2002], having had sex with other men [Stark et al, 1999;Lefrere et al, 1999a;Rey et al, 2000;Berzsenyi et al, 2005], snorting cocaine [Tan et al, 1999], imprisonment [Tan et al, 1999], history of sexually transmitted infections (STIs) [Tan et al, 1999;Bjorkman et al, 2001], healthcare work [Christensen et al, 2003], hospitalization for medical procedures such as delivery and abortion [Lefrere et al, 1999a], endoscopy [Bjorkman et al, 2001], and bronchoscopy [Vanhems et al, 2003], as well as a history of travel to Africa [Lefrere et al, 1999a], schistosomiasis [Hassoba et al, 1997], and exposure to blood-sucking insects [Ribeiro-dos-Santos et al, 2002]. Using a study cohort of 1,387 HIV-infected and 332 HIV-uninfected pregnant women drawn from three perinatal studies in Bangkok, associations between GBV-C RNA and antibody prevalence with demographic, medical, and risk behavior variables were examined to determine the risk factors for GBV-C infection and clearance.…”